SeekPeptides tracks these developments closely, providing evidence-based analysis of every major GLP-1 product, service, and advancement as it emerges
Weeks 14: 0.25 mg once a week Weeks 58: 0.5 mg Weeks 912: 1 mg Weeks 1316: 1.7 mg (if needed) Week 17 and beyond: 2.4 mg (maintenance) Weeks 14: 2.5 mg weekly (starting dose) Week 5+: 5 mg weekly Increase by 2.5 mg every 4 weeks if needed Maximum: 15 mg weekly Your provider will help you determine the right pace based on how youre responding
GLP-1 microdosing allows these patients to access the metabolic benefits while minimizing gastrointestinal discomfort, fatigue, or other adverse reactions
We help patients decide whether medications like Wegovy, Zepbound, Ozempic, Mounjaro, Oral Wegovy, or Foundayo make sense for them, and we help patients understand emerging next-generation options such as retatrutide without confusing investigational data with an available prescription